Candel Therapeutics's total assets for Q2 2025 were $105.97M, an increase of 10.49% from the previous quarter. CADL total liabilities were $15.76M for the fiscal quarter, a -25.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.